For instance, EZH2 has been reported to negatively regulate PD-L1 expression in hepatocellular carcinoma (41), while other studies have shown that shRNA-mediated EZH2 knockdown suppresses both mRNA and protein levels of PD-L1 L1 (42). Here, CD274 is linked to hepatocellular carcinoma.